Cargando…

Reimaging biological barriers affecting distribution and extravasation of PEG/peptide- modified liposomes in xenograft SMMC7721 tumor

Liposomes, as one of the most successful nanotherapeutics, have a major impact on many biomedical areas. In this study, we performed laser scanning confocal microscope (LSCM) and immunohistochemistry (IHC) assays to investigate the intra-tumor transport and antitumor mechanism of GE11 peptide-conjug...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Hailing, Rui, Mengjie, Mai, Junhua, Guo, Wei, Xu, Yuhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049609/
https://www.ncbi.nlm.nih.gov/pubmed/32140398
http://dx.doi.org/10.1016/j.apsb.2019.06.011
_version_ 1783502473052291072
author Tang, Hailing
Rui, Mengjie
Mai, Junhua
Guo, Wei
Xu, Yuhong
author_facet Tang, Hailing
Rui, Mengjie
Mai, Junhua
Guo, Wei
Xu, Yuhong
author_sort Tang, Hailing
collection PubMed
description Liposomes, as one of the most successful nanotherapeutics, have a major impact on many biomedical areas. In this study, we performed laser scanning confocal microscope (LSCM) and immunohistochemistry (IHC) assays to investigate the intra-tumor transport and antitumor mechanism of GE11 peptide-conjugated active targeting liposomes (GE11-TLs) in SMMC7721 xenograft model. According to classification of individual cell types in high resolution images, biodistribution of macrophages, tumor cells, cells with high epidermal growth factor receptor (EGFR) expression and interstitial matrix in tumor microenvironment, in addition, their impacts on intra-tumor penetration of GE11-TLs were estimated. Type I collagen fibers and macrophage flooded in the whole SMMC7721 tumor xenografts. Tumor angiogenesis was of great heterogeneity from the periphery to the center region. However, the receptor-binding site barriers were supposed to be the leading cause of poor penetration of GE11-TLs. We anticipate these images can give a deep reconsideration for rational design of target nanoparticles for overcoming biological barriers to drug delivery.
format Online
Article
Text
id pubmed-7049609
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-70496092020-03-05 Reimaging biological barriers affecting distribution and extravasation of PEG/peptide- modified liposomes in xenograft SMMC7721 tumor Tang, Hailing Rui, Mengjie Mai, Junhua Guo, Wei Xu, Yuhong Acta Pharm Sin B Original article Liposomes, as one of the most successful nanotherapeutics, have a major impact on many biomedical areas. In this study, we performed laser scanning confocal microscope (LSCM) and immunohistochemistry (IHC) assays to investigate the intra-tumor transport and antitumor mechanism of GE11 peptide-conjugated active targeting liposomes (GE11-TLs) in SMMC7721 xenograft model. According to classification of individual cell types in high resolution images, biodistribution of macrophages, tumor cells, cells with high epidermal growth factor receptor (EGFR) expression and interstitial matrix in tumor microenvironment, in addition, their impacts on intra-tumor penetration of GE11-TLs were estimated. Type I collagen fibers and macrophage flooded in the whole SMMC7721 tumor xenografts. Tumor angiogenesis was of great heterogeneity from the periphery to the center region. However, the receptor-binding site barriers were supposed to be the leading cause of poor penetration of GE11-TLs. We anticipate these images can give a deep reconsideration for rational design of target nanoparticles for overcoming biological barriers to drug delivery. Elsevier 2020-03 2019-07-02 /pmc/articles/PMC7049609/ /pubmed/32140398 http://dx.doi.org/10.1016/j.apsb.2019.06.011 Text en © 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original article
Tang, Hailing
Rui, Mengjie
Mai, Junhua
Guo, Wei
Xu, Yuhong
Reimaging biological barriers affecting distribution and extravasation of PEG/peptide- modified liposomes in xenograft SMMC7721 tumor
title Reimaging biological barriers affecting distribution and extravasation of PEG/peptide- modified liposomes in xenograft SMMC7721 tumor
title_full Reimaging biological barriers affecting distribution and extravasation of PEG/peptide- modified liposomes in xenograft SMMC7721 tumor
title_fullStr Reimaging biological barriers affecting distribution and extravasation of PEG/peptide- modified liposomes in xenograft SMMC7721 tumor
title_full_unstemmed Reimaging biological barriers affecting distribution and extravasation of PEG/peptide- modified liposomes in xenograft SMMC7721 tumor
title_short Reimaging biological barriers affecting distribution and extravasation of PEG/peptide- modified liposomes in xenograft SMMC7721 tumor
title_sort reimaging biological barriers affecting distribution and extravasation of peg/peptide- modified liposomes in xenograft smmc7721 tumor
topic Original article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049609/
https://www.ncbi.nlm.nih.gov/pubmed/32140398
http://dx.doi.org/10.1016/j.apsb.2019.06.011
work_keys_str_mv AT tanghailing reimagingbiologicalbarriersaffectingdistributionandextravasationofpegpeptidemodifiedliposomesinxenograftsmmc7721tumor
AT ruimengjie reimagingbiologicalbarriersaffectingdistributionandextravasationofpegpeptidemodifiedliposomesinxenograftsmmc7721tumor
AT maijunhua reimagingbiologicalbarriersaffectingdistributionandextravasationofpegpeptidemodifiedliposomesinxenograftsmmc7721tumor
AT guowei reimagingbiologicalbarriersaffectingdistributionandextravasationofpegpeptidemodifiedliposomesinxenograftsmmc7721tumor
AT xuyuhong reimagingbiologicalbarriersaffectingdistributionandextravasationofpegpeptidemodifiedliposomesinxenograftsmmc7721tumor